PMV Pharmaceuticals, Inc. (PMVP) Earnings History
Net Loss8 years of earnings data (2018–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
PMV Pharmaceuticals, Inc. (PMVP) Earnings Overview
As of June 23, 2026, PMV Pharmaceuticals, Inc. (PMVP) reported trailing twelve-month net income of -$78M, reflecting -30.0% year-over-year growth. The company earned $-1.47 per diluted share over the past four quarters.
Looking at the long-term picture, PMVP's historical earnings data spans multiple years. The company achieved its highest annual net income of -$18M in fiscal 2018.
PMV Pharmaceuticals, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including RAIN (-$9M net income), KYMR (-$315M net income, -794.4% margin), TNGX (-$107M net income, -162.9% margin), PMVP has comparable earnings metrics. Compare PMVP vs RAIN →
PMVP Earnings vs Peers
Earnings metrics vs comparable public companies
PMVP Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$78M | -32.4% | -$86M | $-1.48 | - | - |
| 2024 | -$59M | +14.9% | -$85M | $-1.14 | - | - |
| 2023 | -$69M | +5.9% | -$80M | $-1.44 | - | - |
| 2022 | -$73M | -26.7% | -$77M | $-1.61 | - | - |
| 2021 | -$58M | -68.0% | -$58M | $-1.28 | - | - |
| 2020 | -$34M | -35.8% | -$35M | $-2.40 | - | - |
| 2019 | -$25M | -44.6% | -$27M | $-0.59 | - | - |
| 2018 | -$18M | - | -$19M | $-5.80 | - | - |
Download Data
Export PMVP earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PMVP — Frequently Asked Questions
Quick answers to the most common questions about buying PMVP stock.
What is PMVP earnings per share (EPS)?
PMVP trailing twelve-month (TTM) diluted EPS is $-1.47, reflecting -30.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2018 to 2025 is available in the table on this page.
What is PMV Pharmaceuticals, Inc.'s net income?
PMV Pharmaceuticals, Inc. (PMVP) trailing twelve-month net income is $-78M as of 2025. Earnings declined -30.0% year-over-year.
Is PMVP profitable?
PMVP is not currently profitable on a TTM basis, reporting a net loss of $-78M. Net margin is N/A. Investors should monitor for a return to profitability.
What is PMVP's earnings growth rate?
PMVP compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2025.
What are PMVP's profit margins?
PMV Pharmaceuticals, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -55.4%.
Is PMVP growing earnings?
PMVP earnings are declining — EPS fell -30.0% year-over-year. TTM net income dropped to $-78M. This contrasts with the 5-year CAGR of N/A.
What was PMVP's best earnings year?
PMV Pharmaceuticals, Inc.'s highest annual net income on record is $-18M, achieved in fiscal year 2018. Earnings history on this page spans 2018 to 2025 and includes all annual and quarterly figures.
What were PMVP's earnings last quarter?
PMVP's most recent reported quarter was Q1 2026. Net income was $-18M with diluted EPS of $-0.34. For a full breakdown of all quarters, see the quarterly earnings table on this page.